Lupus Nephritis Clinical Trials in Michigan

Home | Rheumatology | Lupus Nephritis Clinical Trials

Living With Lupus and Kidney Involvement?

Explore Systemic Lupus Erythematosus & Lupus Nephritis Clinical Trials in Michigan!

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues, causing inflammation and damage to multiple organs. When lupus affects the kidneys, it is known as lupus nephritis, a serious complication that can impair kidney function and lead to long-term health issues if not properly managed. People living with lupus nephritis may experience symptoms such as swelling in the legs or face, foamy urine, fatigue, high blood pressure, and abnormal kidney lab results.

Revive Research Institute is conducting SLE with Lupus Nephritis Clinical Trials in Michigan to evaluate the safety and effectiveness of an investigational medication that can help improve kidney outcomes and disease control in adults with active lupus nephritis.

You may qualify for the SLE with Lupus Nephritis Clinical Trials near you if you are:

To be eligible for our clinical trial for tophaceous gout, individuals must meet the following criteria:

Male & female aged 18 to 75 years
Have a confirmed diagnosis of Systemic Lupus Erythematosus (SLE)
Have active lupus nephritis confirmed by kidney biopsy
Are currently receiving standard lupus nephritis treatment

*Additional criteria may apply

*Take part in paid Lupus Nephritis Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Lupus Nephritis Clinical Trials in Southfield, Michigan or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

Name

This field is for validation purposes and should be left unchanged.

Who is this information for?*(Required)

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

Name(Required)

Phone Number(Required)

Best Time to Call(Required)

Morning

Middle of the day

Evening

Select State(Required)

How did you hear about us?(Required)

Comments

User Agreement(Required)

By Signing up, I agree to be contacted via calls and SMS.

For more info, please visit Privacy Policy.

About SLE with Lupus Nephritis Clinical Trials in Michigan

Systemic Lupus Erythematosus is an autoimmune disease that can affect the skin, joints, blood, brain, and kidneys. Lupus nephritis occurs when lupus-related inflammation damages the kidneys’ ability to filter waste and excess fluid from the blood.

Despite available treatments, many patients continue to experience disease flares, ongoing inflammation, or incomplete response to therapy. Long-term use of steroids and immunosuppressive medications may also lead to unwanted side effects. That’s why SLE and lupus nephritis research studies are essential, to explore new treatment options that may provide better disease control while supporting kidney health.

SLE with Lupus Nephritis Clinical Trials will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with study procedures. The study will compare an investigational oral medication with placebo, alongside standard background therapy, to assess kidney response, disease activity, and safety.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study-related procedures, and visits will be provided at no charge throughout the duration of the study.

Get Started: What to Expect?

If you’re living with systemic lupus erythematosus and lupus nephritis and want to participate in a paid clinical research study, please reach out to us by filling in the form above. One of our study team representatives will contact you to see if you are eligible for this study (pre-screening).

Someone from the research team will ask you to sign an Informed Consent Form (ICF) if you meet the study criteria during the pre-screening process. Once you sign up for the ICF, we will invite you for a screening visit to our clinical site; this will be an initial visit. After that, you will undergo a series of health-related questions and tests to confirm your eligibility as a participant.

Once you receive confirmation of eligibility, you will formally be a part of the SLE with Lupus Nephritis Clinical Trials. You will receive all the information about the research study you might enroll in during the ICF process. We encourage you to ask as many questions as you would like before deciding to participate.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Length of Study

Approx. 104 weeks

No. of Study Visits:

Approx. 20 visits

Location

Michigan

About Systemic Lupus Erythematosus & Lupus Nephritis

Systemic Lupus Erythematosus is a lifelong autoimmune condition that affects millions of people worldwide. Lupus nephritis is one of the most serious complications of lupus and requires close monitoring and timely treatment to protect kidney function.

Common symptoms of Lupus Nephritis include:

Swelling in the legs, ankles, or face
Foamy or bloody urine
Fatigue
High blood pressure
Weight gain from fluid retention
Abnormal kidney blood or urine tests

If left untreated, lupus nephritis can lead to chronic kidney disease or kidney failure. These Lupus Nephritis Clinical Trials aim to evaluate a potential new treatment option for individuals affected by this condition.

Frequently Asked Questions (FAQs)

What is Systemic Lupus Erythematosus (SLE)?

SLE is an autoimmune disease in which the immune system attacks healthy tissues, causing inflammation and damage to various organs, including the kidneys.

What is Lupus Nephritis?

Lupus nephritis is a complication of lupus that affects the kidneys. It can interfere with the kidneys’ ability to filter waste and maintain fluid balance.

Can lupus nephritis be treated?

Yes. Lupus nephritis is typically treated with immunosuppressive medications and steroids. These clinical trials are evaluating an investigational treatment that may help improve kidney outcomes when used alongside standard therapy.

Will my information remain private?

Yes. All your personal and health-related information will be kept confidential under HIPAA (Health Insurance Portability and Accountability Act) guidelines.

Do I have to pay to be a part of the Lupus Nephritis Clinical Trials near me?

Participation in the Lupus Nephritis Clinical Trials in Michigan is free of cost to you and your health insurance. If you qualify and decide to participate, you will be compensated for your time and travel. Details of the stipend will be given to you once you complete the screening process and move on to the informed consent process.

Lupus Nephritis Clinical Trials